Home

dă jos dacă Astrolabe the effect of generic entry on pharmaceutical prices Da naștere Vă rugăm să confirmați dovadă

Generic Price Competition For Specialty Drugs: Too Little, Too Late? |  Health Affairs
Generic Price Competition For Specialty Drugs: Too Little, Too Late? | Health Affairs

The economic and public health impact of intellectual property licensing of  medicines for low-income and middle-income countries: a modelling study -  The Lancet Public Health
The economic and public health impact of intellectual property licensing of medicines for low-income and middle-income countries: a modelling study - The Lancet Public Health

Competition's role in controlling prescription drug prices - Equitable  Growth
Competition's role in controlling prescription drug prices - Equitable Growth

Generic Drug Policies for Developing Countries
Generic Drug Policies for Developing Countries

Generic Price Competition For Specialty Drugs: Too Little, Too Late? |  Health Affairs
Generic Price Competition For Specialty Drugs: Too Little, Too Late? | Health Affairs

Generic Competition and Drug Prices | FDA
Generic Competition and Drug Prices | FDA

The effect of generic market entry on antibiotic prescriptions in the  United States | Nature Communications
The effect of generic market entry on antibiotic prescriptions in the United States | Nature Communications

The effect of inertia on brand-name versus generic drug choices -  ScienceDirect
The effect of inertia on brand-name versus generic drug choices - ScienceDirect

Does NICE influence the adoption and uptake of generics in the UK? |  SpringerLink
Does NICE influence the adoption and uptake of generics in the UK? | SpringerLink

A review of generic medicine pricing in Europe - GaBI Journal
A review of generic medicine pricing in Europe - GaBI Journal

The unexpected consequences of generic entry - ScienceDirect
The unexpected consequences of generic entry - ScienceDirect

Home | OECD iLibrary
Home | OECD iLibrary

Expanding the Use of Generic Drugs | ASPE
Expanding the Use of Generic Drugs | ASPE

How Generic Drugs, Patents, and Price Controls Affect Markets | NBER
How Generic Drugs, Patents, and Price Controls Affect Markets | NBER

PDF) Entry Barriers to Generic Medicines in Malaysia: Policy Implications  for Drug Affordability and Accessibility
PDF) Entry Barriers to Generic Medicines in Malaysia: Policy Implications for Drug Affordability and Accessibility

The effect of patent expiration on sales of branded competitor drugs in a  therapeutic class – DrugPatentWatch - Make Better Decisions
The effect of patent expiration on sales of branded competitor drugs in a therapeutic class – DrugPatentWatch - Make Better Decisions

Generic competition and Drug Prices: New Evidence Linking Greater Generic  Competition and Lower Generic Drug Prices
Generic competition and Drug Prices: New Evidence Linking Greater Generic Competition and Lower Generic Drug Prices

The unexpected consequences of generic entry - ScienceDirect
The unexpected consequences of generic entry - ScienceDirect

Comparing Generic Drug Markets in Europe and the United States: Prices,  Volumes, and Spending - WOUTERS - 2017 - The Milbank Quarterly - Wiley  Online Library
Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending - WOUTERS - 2017 - The Milbank Quarterly - Wiley Online Library

Brand vs generic prescription spending share U.S. 2017-2021 | Statista
Brand vs generic prescription spending share U.S. 2017-2021 | Statista

Patent Expiration and Pharmaceutical Prices | NBER
Patent Expiration and Pharmaceutical Prices | NBER

Brand vs generic drug prescriptions share U.S. 2005-2021 | Statista
Brand vs generic drug prescriptions share U.S. 2005-2021 | Statista

Comparing Generic Drug Markets in Europe and the United States: Prices,  Volumes, and Spending - WOUTERS - 2017 - The Milbank Quarterly - Wiley  Online Library
Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending - WOUTERS - 2017 - The Milbank Quarterly - Wiley Online Library

Does Entry Remedy Collusion? Evidence From the Generic Prescription Drug  Cartel | BFI
Does Entry Remedy Collusion? Evidence From the Generic Prescription Drug Cartel | BFI

Competition and price among brand-name drugs in the same class: A  systematic review of the evidence | PLOS Medicine
Competition and price among brand-name drugs in the same class: A systematic review of the evidence | PLOS Medicine

The consequences of generic entry : price , promotional effort and market  share PRELIMINARY | Semantic Scholar
The consequences of generic entry : price , promotional effort and market share PRELIMINARY | Semantic Scholar

Generic pharmaceutical price decay - Wikipedia
Generic pharmaceutical price decay - Wikipedia

Prescription Drugs: Spending, Use, and Prices | Congressional Budget Office
Prescription Drugs: Spending, Use, and Prices | Congressional Budget Office

Prescription Drugs: Spending, Use, and Prices | Congressional Budget Office
Prescription Drugs: Spending, Use, and Prices | Congressional Budget Office

Limiting Evergreening for Name-Brand Prescription Drugs | Committee for a  Responsible Federal Budget
Limiting Evergreening for Name-Brand Prescription Drugs | Committee for a Responsible Federal Budget